Get started
BIOMARK DIAGNOSTICS INC.BIOMARK DIAGNOSTICS INC.BIOMARK DIAGNOSTICS INC.

BIOMARK DIAGNOSTICS INC.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Seasonals

20B chart


Full chart

Key stats


Market capitalization
‪14.40 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.014 EUR
Net income (FY)
‪−976.55 K‬ EUR
Revenue (FY)
‪111.67 K‬ EUR
Shares float
‪39.30 M‬
Beta (1Y)
−0.42

About BIOMARK DIAGNOSTICS INC.


Sector
Health Services
Industry
Medical/Nursing Services
CEO
Rashid Ahmed Maula Bux
Website
biomarkdiagnostics.com
Headquarters
Richmond
Founded
2014
FIGI
BBG007LXD8B4
BioMark Diagnostics, Inc. is a canadian-based company, which engages in the development and commercialization of cancer diagnostic solutions to detect, monitor, and assess treatment for cancer. The company was founded by Rashid Ahmed Maula Bux on June 19, 2014 and is headquartered in Richmond, Canada.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

20B news



Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as 20B.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange BIOMARK DIAGNOSTICS INC. stocks are traded under the ticker 20B.
20B reached its all-time high on Nov 26, 2014 with the price of 0.656 EUR, and its all-time low was 0.001 EUR and was reached on Oct 18, 2016. View more price dynamics on 20B chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track BIOMARK DIAGNOSTICS INC. financials in yearly and quarterly reports right on TradingView.
20B net income for the last quarter is ‪−224.72 K‬ EUR, while the quarter before that showed ‪−363.29 K‬ EUR of net income which accounts for 38.14% change. Track more BIOMARK DIAGNOSTICS INC. financial stats to get the full picture.
No, 20B doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOMARK DIAGNOSTICS INC. EBITDA is ‪−1.17 M‬ EUR, and current EBITDA margin is −866.03%. See more stats in BIOMARK DIAGNOSTICS INC. financial statements.
Like other stocks, 20B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOMARK DIAGNOSTICS INC. stock right from TradingView charts — choose your broker and connect to your account.